News Aera Tx launches with $193m in financing for genetic meds Aera Therapeutics announces launch with $193m financing from leading life sciences investors.
News Lynparza under siege in first-line prostate cancer New data from Pfizer and J&J encroach on AZ and Merck's territory with the PARP inhibitor.
News Maxion Therapeutics gets $16m Series A Financing LifeArc Ventures leads $16m Series A of Maxion Therapeutics for antibody development overhaul.
News New VC Curie.bio makes its debut with $500m+ war chest New venture capital fund for biotech, Curie.bio launches with 'whole new model for financing'.
News Ipsen announces CheckMate 3-yr follow-up aRCC results Ipsen has announced the three-year follow up results from its CheckMate -9ER study
News Shkreli claims Druglike isn’t a drug company Shkreli says two companies set up since his release from prison do not violate his pharma ban
News Parexel buys Vitrana to boost patient safety toolkit Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed sum.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
